Free to download, free to cite
The public fields behind every Amiravo page, for 111 compounds, as CSV and JSON under CC BY 4.0. Regenerated from the same source as the site.
Amiravo compound reference fields
One row per library compound: names and aliases, research area, class, evidence grade and label, regulatory status, CAS, PubChem CID, UNII, ChEMBL and DrugBank identifiers, molecular formula and weight, last review date and page URL.
State of Peptide Research 2026 statistics
Per-compound counts of PubMed publications (human, animal-only, in vitro, randomized trials, reviews, by year), registered trials and highest phase from ClinicalTrials.gov, FAERS report counts and NIH-funded projects.
License and citation
Both datasets are licensed CC BY 4.0: use, share and adapt them, including commercially, with attribution.
Amiravo. “Amiravo compound reference fields” and “State of Peptide Research 2026 statistics”. amiravo.com/data, accessed [date]. CC BY 4.0.
Evidence grades are editorial judgements made by reading the cited studies; counts measure research volume, not quality. Neither is medical advice.
Press
- Amiravo is an independent reference library for research peptides. It summarizes published studies, drug labels and regulatory records, labels the strength of the evidence, and sells nothing.
- Every compound page cites its sources, shows a dated revision history and states what is not known.
- Figures you can quote come from the State of Peptide Research 2026 report and the datasets above.
- Methods for every number on the site are on the methodology page.
Questions, corrections or interview requests: contact the editorial team.
Download the Amiravo card image